Why the study?
Do aspirin and morphine diminish the N120 component of somatosensory evoked potentials in normal adults compared to placebo?
Do aspirin and morphine diminish the N120 component of somatosensory evoked potentials in normal adults compared to placebo?
Answers are grounded in this paper and cite their sources.
Aspirin and morphine significantly diminish the N120 component of somatosensory evoked potentials at high stimulus intensities in normal adults.
Somatosensory evoked potentials (EPs) to stimuli ranging from barely perceptible to painful were recorded in 153 normal adults. Reliability of amplitude and amplitude/intensity slopes were demonstrated in 29 individuals tested twice, two or more weeks apart. In randomized, double-blind placebo controlled trials, both aspirin and morphine significantly diminished N120 component at high stimulus intensities. Age, sex and pharmacological effects paralleled those found with psychophysical techniques in part I of this study.
No takes yet. Share an insight, caveat, or question.
Buchsbaum et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: